Astellas and Poseida Therapeutics Plan to Invest in Redefining Cancer Cell Therapy

Additionally, Poseida has approved Astellas as a board observer seat, which gives Astellas the right to attend Poseida’s scientific advisory board meetings and certain notice rights related to any potential change of control over Poseida.